Edition:
United States

Allena Pharmaceuticals Inc (ALNA.OQ)

ALNA.OQ on NASDAQ Stock Exchange Global Select Market

10.35USD
4:00pm EDT
Change (% chg)

$-1.07 (-9.37%)
Prev Close
$11.42
Open
$11.42
Day's High
$11.42
Day's Low
$10.20
Volume
65,356
Avg. Vol
31,717
52-wk High
$17.55
52-wk Low
$6.15

Chart for

About

Allena Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing non-systemic oral protein therapeutics to treat metabolic and orphan diseases, with a particular focus on nephrologic and urologic conditions. Its lead product candidate, ALLN-177, is in an ongoing Phase II... (more)

Overall

Beta: --
Market Cap(Mil.): $236.99
Shares Outstanding(Mil.): 20.75
Dividend: --
Yield (%): --

Financials

  ALNA.OQ Industry Sector
P/E (TTM): -- 108.45 32.71
EPS (TTM): -1.35 -- --
ROI: -49.89 1.54 12.72
ROE: -- 0.30 14.84

BRIEF-Allena Pharmaceuticals Reports Q1 Loss Per Share $0.38

* ALLENA PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

May 08 2018

BRIEF-Allena Pharmaceuticals Reports Qtrly Net Loss Per Share Attributable To Common Stockholders $0.48

* ALLENA PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

Mar 27 2018

Earnings vs. Estimates